DexCom, Inc. (LON:0A4M)
London · Delayed Price · Currency is GBP · Price in USD 62.79
+3.27 (5.50%)
At close: Dec 1, 2025
DexCom Market Cap
DexCom has a market cap or net worth of 19.26 billion as of December 19, 2025. Its market cap has decreased by -22.59% in one year.
Market Cap
19.26B
Enterprise Value
18.71B
Revenue
3.36B
Ranking
n/a
PE Ratio
35.93
Stock Price
62.79
Market Cap Chart
Since April 14, 2005, DexCom's market cap has increased from 157.23M to 19.26B, an increase of 12,152.10%. That is a compound annual growth rate of 26.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 19.26B | -20.60% |
| Dec 31, 2024 | 24.26B | -35.54% |
| Dec 29, 2023 | 37.64B | 3.69% |
| Dec 30, 2022 | 36.30B | -5.55% |
| Dec 31, 2021 | 38.43B | 47.80% |
| Dec 31, 2020 | 26.00B | 72.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.09B |
| HSBC Holdings | 197.25B |
| Shell | 152.57B |
| Unilever | 108.28B |
| Rio Tinto Group | 98.82B |
| Rolls-Royce Holdings | 95.76B |
| British American Tobacco p.l.c. | 93.12B |
| GSK plc | 72.73B |